Tune Therapeutics, a pioneering epigenome editing company based in Durham, NC, is at the forefront of developing a new and potentially curative approach to treating chronic HBV infection.
The company's innovative program focuses on epigenetic editing to address this challenging medical condition, offering hope for improved treatment outcomes in the future.
Generated from the website